Oct
2026
Fiera Milano, Italy
Visit us
stand 3K54, API

Suli Pharmaceutical Technology Jiangyin Co., Ltd.

Exhibitor at CPHI Milan 2026
About Us

Suli Pharma is a wholly owned subsidiary of Suli Group, was established in 2009, consisting of Suli Pharma Shanghai R&D Center, Suli Pharma Jiangyin Production Site and Dalian Yongda-Suli Pharma. Suli Pharma is committed to providing our worldwide clients the CRO/CDMO services of the APIs and pharmaceutical intermediates from lab scale R&D, to process development, to  pilot production and commercial production.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • Founded:
    2009
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Pharmaceutical company
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 3K54, API

Products Featured at CPHI Milan 2026